The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Do Statins Reduce Risk of Incident Dementia and Alzheimer Disease?<subtitle>The Cache County Study</subtitle>
Abstract
BACKGROUND: Prior reports suggest reduced occurrence of dementia and Alzheimer disease (AD) in statin users, but, to our knowledge, no prospective studies relate statin use and dementia incidence. OBJECTIVE: To examine the association of statin use with both prevalence and incidence of dementia and AD. DESIGN: Cross-sectional studies of prevalence and incidence and a prospective study of incidence of dementia and AD among 5092 elderly residents (aged 65 years or older) of a single county. Participants were assessed at home in 1995-1997 and again in 1998-2000. A detailed visual inventory of medicines, including statins and other lipid-lowering agents, was collected at both assessments. MAIN OUTCOME MEASURES: Diagnosis of dementia and of AD. RESULTS: From 4895 participants with data sufficient to determine cognitive status, we identified 355 cases of prevalent dementia (200 with AD) at initial assessment. Statin use was inversely associated with prevalence of dementia (adjusted odds ratio, 0.44; 95% confidence interval, 0.17-0.94). Three years later, we identified 185 cases of incident dementia (104 with AD) among 3308 survivors at risk. Statin use at baseline did not predict incidence of dementia or AD (adjusted hazard ratio for dementia, 1.19; 95% confidence interval, 0.53-2.34; adjusted hazard ratio for AD, 1.19; 95% confidence interval, 0.35-2.96), nor did statin use at follow-up (adjusted odds ratio for dementia, 1.04; 95% confidence interval, 0.56-1.81; adjusted odds ratio for AD, 0.85; 95% confidence interval, 0.32-1.88). CONCLUSIONS: Although statin use might be less frequent in those with prevalent dementia, we found no association between statin use and subsequent onset of dementia or AD. Further research is warranted before costly dementia prevention trials with statins are undertaken.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
(1987) · PubMed · Cited by 2,657
Statins and the risk of dementia
Jick, H., Zornberg, G., Jick, S., Seshadri, S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,759
Event History Analysis : Regression for Longitudinal Event Data
Allison, P. D. (1984) · Cited by 1,711
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618
Wolozin, B. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1439 · Cited by 1,398
Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons
Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C. G., & Simons, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6460 · Cited by 1,166
Jorm, A. F., & Jacomb, P. A. (1989) · Psychological Medicine · doi:10.1017/s0033291700005742 · Cited by 1,114
Hofman, A., Ott, A., Breteler, M. M., Bots, M. L., Slooter, A. J., van Harskamp, F., van Duijn, C. N., Van Broeckhoven, C., & Grobbee, D. E. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09328-2 · Cited by 1,062
Zandi, P. P. (2002) · JAMA · doi:10.1001/jama.288.17.2123 · Cited by 906
Self-citationFassbender, K., Simons, M., Bergmann, C., Stroick, M., Lütjohann, D., Keller, P., Runz, H., Kühl, S., Bertsch, T., von Bergmann, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081620098 · Cited by 860
Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model
Refolo, L. M., Pappolla, M. A., Malester, B., LaFrancois, J., Bryant-Thomas, T., Wang, R., Tint, G. S., Sambamurti, K., & Duff, K. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0304 · Cited by 783
Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease
Notkola, I.-L., Sulkava, R., Pekkanen, J., Erkinjuntti, T., Ehnholm, C., Kivinen, P., Tuomilehto, J., & Nissinen, A. (1998) · Neuroepidemiology · doi:10.1159/000026149 · Cited by 669
Pahan, K., Sheikh, F. G., Namboodiri, A. M., & Singh, I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119812 · Cited by 571
Rockwood, K., Kirkland, S., Hogan, D. B., MacKnight, C., Merry, H., Verreault, R., Wolfson, C., & McDowell, I. (2002) · Archives of Neurology · doi:10.1001/archneur.59.2.223 · Cited by 516
Sparks, D. L., Scheff, S. W., Hunsaker, J. C., Liu, H., Landers, T., & Gross, D. R. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1044 · Cited by 443
Serum Lipoprotein Levels, Statin Use, and Cognitive Function in Older Women
Yaffe, K., Barrett-Connor, E., Lin, F., & Grady, D. (2002) · Archives of Neurology · doi:10.1001/archneur.59.3.378 · Cited by 439
APOE -ε4 count predicts age when prevalence of AD increases, then declines: The Cache County Study
Breitner, J. C. S., Wyse, B. W., Anthony, J. C., Welsh-Bohmer, K. A., Steffens, D. C., Norton, M. C., Tschanz, J. T., Plassman, B. L., Meyer, M. R., Skoog, I., et al. (1999) · Neurology · doi:10.1212/wnl.53.2.321 · Cited by 397
Incidence of AD may decline in the early 90s for men, later for women: The Cache County study
Miech, R. A., Breitner, J. C. S., Zandi, P. P., Khachaturian, A. S., Anthony, J. C., & Mayer, L. (2002) · Neurology · doi:10.1212/wnl.58.2.209 · Cited by 331
Self-citationThe role of cholesterol in the biosynthesis of β-amyloid.
Frears, E. R., Stephens, D. J., Walters, C. E., Davies, H., & Austen, B. M. (1999) · NeuroReport · doi:10.1097/00001756-199906030-00014 · Cited by 324
Reduced incidence of AD with NSAID but not H2receptor antagonists: The Cache County Study
Zandi, P. P., Anthony, J. C., Hayden, K. M., Mehta, K., Mayer, L., & Breitner, J. C. S. (2002) · Neurology · doi:10.1212/wnl.59.6.880 · Cited by 316
Self-citationStatin therapy and risk of dementia in the elderly: A community-based prospective cohort study
Li, G., Higdon, R., Kukull, W. A., Peskind, E., Van Valen Moore, K., Tsuang, D., van Belle, G., McCormick, W., Bowen, J. D., Teri, L., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000142963.90204.58 · Cited by 246
Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: The Cache County Study
Anthony, J. C., Breitner, J. C. S., Zandi, P. P., Meyer, M. R., Jurasova, I., Norton, M. C., & Stone, S. V. (2000) · Neurology · doi:10.1212/wnl.54.11.2066 · Cited by 224
Self-citationLow-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke
Moroney, J. T. (1999) · JAMA · doi:10.1001/jama.282.3.254 · Cited by 222
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.10.1279 · Cited by 207
Current and future treatment of hyperlipidemia: the role of statins
Farnier, M., & Davignon, J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00423-8 · Cited by 193
Hajjar, I., Schumpert, J., Hirth, V., Wieland, D., & Eleazer, G. P. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.7.m414 · Cited by 189
Treating Nondementia Illnesses in Patients With Dementia
Brauner, D. J. (2000) · JAMA · doi:10.1001/jama.283.24.3230 · Cited by 163
Racchi, M., Baetta, R., Salvietti, N., Ianna, P., Franceschini, G., Paoletti, R., Fumagalli, R., Govoni, S. M., Trabucchi, M., & Soma, M. R. (1997) · Biochemical Journal · doi:10.1042/bj3220893 · Cited by 154
Boudreau, D. M., Daling, J. R., Malone, K. E., Gardner, J. S., Blough, D. K., & Heckbert, S. R. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh038 · Cited by 125
HMG-CoA reductase inhibitors (statins): A promising approach to stroke prevention
Hess, D. C., Demchuk, A. M., Brass, L. M., & Yatsu, F. M. (2000) · Neurology · doi:10.1212/wnl.54.4.790 · Cited by 113
Santanello, N. C., Barber, B., Applegate, W. B., Elam, J. T., Curtis, C., Hunninghake, D. B., Gordon, D. J., & For the CRISP Collaborative Study Group (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb00971.x · Cited by 101
Rodríguez, E., Dodge, H. H., Birzescu, M., Stoehr, G. P., & Ganguli, M. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50515.x · Cited by 90
Sparks, D. L., Connor, D. J., Browne, P. J., Lopez, J. E., & Sabbagh, M. N. (2002) · PubMed · Cited by 82
Performance characteristics of a two-stage dementia screen in a population sample
Khachaturian, A. S., Gallo, J. J., & Breitner, J. C. S. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00196-1 · Cited by 74
Haley, R. W., & Dietschy, J. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1410 · Cited by 74
Treatment for the Secondary Prevention of Stroke in Older Patients: The Influence of Dementia Status
Moroney, J. T., Tseng, C., Paik, M. C., Mohr, J. P., & Desmond, D. W. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb03839.x · Cited by 66
Characteristics of a two-stage screen for incident dementia
Hayden, K. M., Khachaturian, A. S., Tschanz, J. T., Corcoran, C., Nortond, M., Breitner, J. C. S., & for the Cache County Study Group (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00247-6 · Cited by 54
Zandi, P. P. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.82 · Cited by 47
Self-citationUrmoneit, B., Turner, J. D., & Dyrks, T. (1998) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(98)00032-x · Cited by 15
Cited by
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
Qiu, C., Kivipelto, M., & von Strauss, E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/cqiu · Cited by 1,261
The Alzheimer's disease Beta-secretase enzyme, BACE1
Cole, S. L., & Vassar, R. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-22 · Cited by 550
Statins for the prevention of dementia
McGuinness, B., Craig, D., Bullock, R., & Passmore, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160.pub3 · Cited by 490
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
Gazzerro, P., Proto, M. C., Gangemi, G., Malfitano, A. M., Ciaglia, E., Pisanti, S., Santoro, A., Laezza, C., & Bifulco, M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004994 · Cited by 457
Metadata
- Authors
- Zandi, P. P.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2005-02-01
- Volume
- 62
- Issue
- 2
- Pages
- 217
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W1998664054
- Cited by
- 310
- References
- 42
- FWCI
- 20.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.